Alembic Pharmaceuticals informs about press release

01 Apr 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received one US Food & Drug Administration (USFDA) Product Approval (Tentative) during the quarter ended 31st March, 2024. The summary statement giving brief of the product approval received during the quarter ended 31st March, 2024 is enclosed. Alembic has a cumulative total of 197 ANDA approvals (170 final approvals and 27 tentative approvals) from USFDA. Press release of same is enclosed.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1055.00 4.85 (0.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.